Nature Mental Health, Published online: 12 January 2024; doi:10.1038/s44220-023-00187-w
Using a large multi-center neuroimaging dataset, Fu, Antoniades et al. reveal that major depressive disorder is characterized by two neuroanatomical dimensions exhibiting distinct treatment response to placebo and selective serotonin reuptake inhibitor medications.